Financing led by Ampersand Capital Partners with significant support from Genezen’s management team and advisors Proceeds from financing will enable expansion of Genezen’s viral vector development and manufacturing capacity and capabilities Pipeline of multiple client programs are fueling…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.